Evidence map›Paper›PMID 32957471›Full record

ArticleAntibiotics (Basel, Switzerland)2020

Synthesis, ADMET Properties, and In Vitro Antimicrobial and Antibiofilm Activity of 5-Nitro-2-thiophenecarbaldehyde N-((E)-(5-Nitrothienyl)methylidene)hydrazone (KTU-286) against

Povilas Kavaliauskas, Birute Grybaite, Vytautas Mickevicius, Ruta Petraitiene, Ramune Grigaleviciute, Rita Planciuniene, Philip Gialanella, Alius Pockevicius, Vidmantas Petraitis

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Povilas KavaliauskasDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine of Cornell University, New York, NY 10065, USA.ORCID 0000-0003-0237-9088
Birute GrybaiteDepartment of Organic Chemistry, Kaunas University of Technology, 50254 Kaunas, Lithuania.
Vytautas MickeviciusDepartment of Organic Chemistry, Kaunas University of Technology, 50254 Kaunas, Lithuania.
Ruta PetraitieneDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine of Cornell University, New York, NY 10065, USA.
Ramune GrigaleviciuteBiological Research Center, Lithuanian University of Health Sciences, 47181 Kaunas, Lithuania.
Rita PlanciunieneInstitute of Microbiology and Virology, Lithuanian University of Health Sciences, 47181 Kaunas, Lithuania.
Philip GialanellaDepartment of Pathology, Montefiore Medical Center and Albert Einstein College of Medicine, New York, NY 10467, USA.
Alius PockeviciusDepartment of Veterinary Pathobiology, Lithuanian University of Health Sciences, 47181 Kaunas, Lithuania.
Vidmantas PetraitisDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine of Cornell University, New York, NY 10065, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of drug-resistant

Indexed as

antimicrobialbisnitrothiophenedrug resistanthydrazoneMRSAsmall moleculesStaphylococcus aureusthiophene derivativesVRSA

Identifiers

PMID32957471
PMCPMC7558474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.